Press Releases
-
SK bioscience’s COVID-19 vaccine candidate, ‘GBP510’ secures up to 173.4 million USD of additional ...2021. 05. 24 -
SK bioscience’s Novavax’ COVID-19 vaccine candidate facility obtained GMP certification from the EMA...2021. 05. 17 -
IPO listing ceremony held at the Korea Exchange on the 18th- “Another leap forward as a global compa...2021. 03. 18 -
- CEPI grants up to 14.2 million USD of funding to support development of a vaccine against COVID-1...2021 .03 .11 -
- SK bioscience obtained exclusive rights to manufacture, marketing, and distribute the NVX-CoV237...2021 .02 .16 -
Korea Exchange grants preliminary approval on the 4th Subscriptions to the public offering will be ...2021. 02. 08 -
SK bioscience Collaborates with GSK on COVID-19 Vaccine Development and Initiate Phase I/II Trial ...2021. 02. 05 -
SK bioscience-GlaxoSmithKlein(GSK) co-promote five vaccines against Tdap, hepatitis A, meningococca...2021. 01. 06 -
- SK bioscience will apply for a certification for export from the Ministry of Food and Drug Safety(...2020. 12. 17 -
- SK bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) cooperate in develop...2020. 12. 10 -
SK bioscience will enter clinical trials of NBP2001 upon the IND approval from the Ministry of Foo...2020. 12. 02 -
- SK bioscience will submit an application for preliminary screening to the Korea Exchange (KRX) fo...2020. 11. 30